FDA Approval Insights: Tivozanib in Relapsed/Refractory Advanced RCC
Season 1, Episode 1, Jun 03, 2021, 07:58 PM
Dr. Rini discusses unique elements of the TIVO-3 trial, the significance of the FDA approval of tivozanib in advanced RCC, and potential next steps for research with the TKI in the paradigm.